ESM1 and ovarian neoplasm: To the best of our knowledge, only one study has been published on immunohistochemically Endocan expression in ovarian tumors , which introduced Endocan-MVD as an independent prognostic marker for overall survival of epithelial ovarian cancer (P<0.01).